MedPath

??Effect of Tranexamic acid in treatment of surgical bleeding

Phase 3
Conditions
staghorn calculus kidney.
Calculus of kidney and ureter
Registration Number
IRCT20180209038673N1
Lead Sponsor
Reseach depurty of Isfahan University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

patients with staghorn calculus candidate for percutaneous nephrolithotomy surgery

Exclusion Criteria

renal failure
creatinine more than 15
consumption of vitamin E, Aspirin and warfarin

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding. Timepoint: One week after the end intervention. Method of measurement: The amount of blood intake.
Secondary Outcome Measures
NameTimeMethod
Hemoglobin. Timepoint: One week after the end intervention. Method of measurement: CBC analysis.
© Copyright 2025. All Rights Reserved by MedPath